<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Focal_segmental_glomerulosclerosis</id>
	<title>Focal segmental glomerulosclerosis - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Focal_segmental_glomerulosclerosis"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;action=history"/>
	<updated>2026-04-17T07:05:44Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;diff=389426&amp;oldid=prev</id>
		<title>Danbot: Strip excess bold</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;diff=389426&amp;oldid=prev"/>
		<updated>2026-03-22T09:36:51Z</updated>

		<summary type="html">&lt;p&gt;Strip excess bold&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:36, 22 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l33&quot;&gt;Line 33:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 33:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Clinical features==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==Clinical features==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Nephrotic syndrome (&amp;gt;70% of primary FSGS)===&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;===Nephrotic syndrome (&amp;gt;70% of primary FSGS)===&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Edema: generalized or dependent; may develop over weeks or have &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;abrupt onset with 15-20 lb weight gain&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&amp;lt;ref name=&amp;quot;Medscape_FSGS&amp;quot;&amp;gt;Focal Segmental Glomerulosclerosis Clinical Presentation. ''Medscape''. 2024.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Edema: generalized or dependent; may develop over weeks or have abrupt onset with 15-20 lb weight gain&amp;lt;ref name=&amp;quot;Medscape_FSGS&amp;quot;&amp;gt;Focal Segmental Glomerulosclerosis Clinical Presentation. ''Medscape''. 2024.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Children: typically begins with &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;periorbital/facial swelling&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;→ progresses to generalized anasarca&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Children: typically begins with periorbital/facial swelling → progresses to generalized anasarca&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Adults: dependent edema (legs, sacrum); periorbital&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Adults: dependent edema (legs, sacrum); periorbital&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Foamy urine (proteinuria)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Foamy urine (proteinuria)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Fatigue, anorexia&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Fatigue, anorexia&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Ascites, pleural effusions (from third-spacing; pericardial effusion is rare)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Ascites, pleural effusions (from third-spacing; pericardial effusion is rare)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Onset frequently follows an &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;upper respiratory tract infection&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Onset frequently follows an upper respiratory tract infection&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Hypertension — may be '''severe''' (diastolic &amp;gt;120 mmHg), especially in Black patients with renal impairment&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Hypertension — may be '''severe''' (diastolic &amp;gt;120 mmHg), especially in Black patients with renal impairment&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l53&quot;&gt;Line 53:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 53:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Thromboembolism====&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Thromboembolism====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Nephrotic syndrome is a '''hypercoagulable state''' — urinary loss of antithrombin III, protein C, protein S; elevated fibrinogen, factor V, factor VIII; platelet hyperaggregability&amp;lt;ref name=&amp;quot;Complications&amp;quot;&amp;gt;Complications of nephrotic syndrome. ''Korean J Pediatr''. 2011;54(8):322-328. PMC3212701.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Nephrotic syndrome is a '''hypercoagulable state''' — urinary loss of antithrombin III, protein C, protein S; elevated fibrinogen, factor V, factor VIII; platelet hyperaggregability&amp;lt;ref name=&amp;quot;Complications&amp;quot;&amp;gt;Complications of nephrotic syndrome. ''Korean J Pediatr''. 2011;54(8):322-328. PMC3212701.&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Risk: &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;deep venous thrombosis, pulmonary embolism, renal vein thrombosis, cerebral sinus thrombosis&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Risk: deep venous thrombosis, pulmonary embolism, renal vein thrombosis, cerebral sinus thrombosis&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*VTE incidence ~1-5% in adults (higher in membranous nephropathy); risk is highest in the &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;first 6 months&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*VTE incidence ~1-5% in adults (higher in membranous nephropathy); risk is highest in the first 6 months&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Sudden gross hematuria or acute flank pain + acute renal failure → suspect &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;renal vein thrombosis&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Sudden gross hematuria or acute flank pain + acute renal failure → suspect renal vein thrombosis&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Acute dyspnea + pleuritic chest pain → suspect &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;pulmonary embolism&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Acute dyspnea + pleuritic chest pain → suspect pulmonary embolism&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Children: arterial thrombosis (cerebrovascular) can also occur&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Children: arterial thrombosis (cerebrovascular) can also occur&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l62&quot;&gt;Line 62:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 62:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Immunodeficiency from urinary loss of immunoglobulins (especially IgG) and complement proteins&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Immunodeficiency from urinary loss of immunoglobulins (especially IgG) and complement proteins&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Immunosuppressive therapy further increases risk&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Immunosuppressive therapy further increases risk&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Most common infections: pneumonia, sepsis/bacteremia, cellulitis, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;spontaneous bacterial peritonitis (SBP)&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;, UTI&amp;lt;ref name=&amp;quot;Complications&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Most common infections: pneumonia, sepsis/bacteremia, cellulitis, spontaneous bacterial peritonitis (SBP), UTI&amp;lt;ref name=&amp;quot;Complications&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* SBP in nephrotic syndrome: any child with nephrotic syndrome + fever + abdominal pain + ascites should have &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;diagnostic paracentesis&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;— ''Streptococcus pneumoniae'' is the most common causative organism; ''E. coli'' and gram-negatives also seen&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* SBP in nephrotic syndrome: any child with nephrotic syndrome + fever + abdominal pain + ascites should have diagnostic paracentesis — ''Streptococcus pneumoniae'' is the most common causative organism; ''E. coli'' and gram-negatives also seen&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Steroid therapy may &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;mask typical signs of infection&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;— maintain a high index of suspicion&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Steroid therapy may mask typical signs of infection — maintain a high index of suspicion&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Hypovolemic crisis====&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;====Hypovolemic crisis====&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Severe hypoalbuminemia (albumin &amp;lt;1.5 g/dL) → decreased oncotic pressure → intravascular volume depletion&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Severe hypoalbuminemia (albumin &amp;lt;1.5 g/dL) → decreased oncotic pressure → intravascular volume depletion&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Abdominal pain, vomiting, diarrhea, tachycardia, cool extremities, delayed capillary refill, oliguria → &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;hypotension&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(a late sign)&amp;lt;ref name=&amp;quot;Complications&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Abdominal pain, vomiting, diarrhea, tachycardia, cool extremities, delayed capillary refill, oliguria → hypotension (a late sign)&amp;lt;ref name=&amp;quot;Complications&amp;quot;/&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Can be precipitated by aggressive diuresis or intercurrent illness&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Can be precipitated by aggressive diuresis or intercurrent illness&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Risk of AKI from prerenal azotemia&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Risk of AKI from prerenal azotemia&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l102&quot;&gt;Line 102:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 102:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Urinalysis with microscopy:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Urinalysis with microscopy:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Heavy proteinuria (3+ or 4+ on dipstick)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;** Heavy proteinuria (3+ or 4+ on dipstick)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Hyaline or broad waxy casts; &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;RBC casts are generally absent&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(their presence suggests nephritic syndrome/glomerulonephritis instead)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Hyaline or broad waxy casts; RBC casts are generally absent (their presence suggests nephritic syndrome/glomerulonephritis instead)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Oval fat bodies (&amp;quot;Maltese cross&amp;quot; under polarized light) — pathognomonic for nephrotic-range proteinuria&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Oval fat bodies (&amp;quot;Maltese cross&amp;quot; under polarized light) — pathognomonic for nephrotic-range proteinuria&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Spot urine protein:creatinine ratio: &amp;gt;3.5 mg/mg indicates nephrotic-range proteinuria (faster than 24-hour collection)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Spot urine protein:creatinine ratio: &amp;gt;3.5 mg/mg indicates nephrotic-range proteinuria (faster than 24-hour collection)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l134&quot;&gt;Line 134:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 134:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* IV albumin 25% (0.5-1 g/kg) followed immediately by IV furosemide: for '''severe/refractory edema''' or clinical hypovolemia&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* IV albumin 25% (0.5-1 g/kg) followed immediately by IV furosemide: for '''severe/refractory edema''' or clinical hypovolemia&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Albumin temporarily raises oncotic pressure, mobilizes edema fluid into intravascular space, and enhances diuretic delivery to the kidney&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Albumin temporarily raises oncotic pressure, mobilizes edema fluid into intravascular space, and enhances diuretic delivery to the kidney&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Monitor closely for pulmonary edema&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;— albumin infusion can cause fluid overload if the patient is not truly volume-depleted&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Monitor closely for pulmonary edema — albumin infusion can cause fluid overload if the patient is not truly volume-depleted&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*'''Do NOT give albumin without concurrent diuresis''' unless treating confirmed hypovolemia — it will redistribute into the extravascular space and worsen edema&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*'''Do NOT give albumin without concurrent diuresis''' unless treating confirmed hypovolemia — it will redistribute into the extravascular space and worsen edema&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l179&quot;&gt;Line 179:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 179:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Counsel patients on:&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Counsel patients on:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Sodium restriction&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Sodium restriction&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Signs of thromboembolism&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(leg swelling, dyspnea, chest pain) — seek immediate care&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Signs of thromboembolism (leg swelling, dyspnea, chest pain) — seek immediate care&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Signs of infection&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(fever, abdominal pain) — low threshold to return&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Signs of infection (fever, abdominal pain) — low threshold to return&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Medication compliance (steroids, immunosuppressants, ACE inhibitors)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Medication compliance (steroids, immunosuppressants, ACE inhibitors)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;'''&lt;/del&gt;Pneumococcal vaccination&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;''' &lt;/del&gt;(if not already received — nephrotic patients are at high risk for pneumococcal infection)&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;**Pneumococcal vaccination (if not already received — nephrotic patients are at high risk for pneumococcal infection)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==See Also==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;==See Also==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;diff=386197&amp;oldid=prev</id>
		<title>Danbot: Moved intro paragraph into Background section as bullets; removed excessive bold from bullet lead-ins throughout; added Periorbital swelling DDX template transclusion; bold retained only for critical warnings and counseling points</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;diff=386197&amp;oldid=prev"/>
		<updated>2026-03-19T12:51:56Z</updated>

		<summary type="html">&lt;p&gt;Moved intro paragraph into Background section as bullets; removed excessive bold from bullet lead-ins throughout; added Periorbital swelling DDX template transclusion; bold retained only for critical warnings and counseling points&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;amp;diff=386197&amp;amp;oldid=386167&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;diff=386167&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;Focal segmental glomerulosclerosis (FSGS) is a pattern of '''glomerular scarring''' in which sclerosis affects '''segments''' (not the entirety) of '''some''' (not all) glomeruli.&lt;ref name=&quot;StatPearls&quot;&gt;Focal Segmental Glomerulosclerosis. ''StatPearls''. NCBI. 2024.&lt;/ref&gt; It is the '''most common cause of primary (idiopathic) nephrotic syndrome in adults''' in the United States and the '''leading glomerular cause of end-stage kidney disease (ESKD)'''.&lt;ref name=&quot;CJASN&quot;&gt;Ros...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Focal_segmental_glomerulosclerosis&amp;diff=386167&amp;oldid=prev"/>
		<updated>2026-03-18T01:22:57Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Focal segmental glomerulosclerosis (FSGS) is a pattern of &amp;#039;&amp;#039;&amp;#039;glomerular scarring&amp;#039;&amp;#039;&amp;#039; in which sclerosis affects &amp;#039;&amp;#039;&amp;#039;segments&amp;#039;&amp;#039;&amp;#039; (not the entirety) of &amp;#039;&amp;#039;&amp;#039;some&amp;#039;&amp;#039;&amp;#039; (not all) glomeruli.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Focal Segmental Glomerulosclerosis. &amp;#039;&amp;#039;StatPearls&amp;#039;&amp;#039;. NCBI. 2024.&amp;lt;/ref&amp;gt; It is the &amp;#039;&amp;#039;&amp;#039;most common cause of primary (idiopathic) nephrotic syndrome in adults&amp;#039;&amp;#039;&amp;#039; in the United States and the &amp;#039;&amp;#039;&amp;#039;leading glomerular cause of end-stage kidney disease (ESKD)&amp;#039;&amp;#039;&amp;#039;.&amp;lt;ref name=&amp;quot;CJASN&amp;quot;&amp;gt;Ros...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Focal segmental glomerulosclerosis (FSGS) is a pattern of '''glomerular scarring''' in which sclerosis affects '''segments''' (not the entirety) of '''some''' (not all) glomeruli.&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;&amp;gt;Focal Segmental Glomerulosclerosis. ''StatPearls''. NCBI. 2024.&amp;lt;/ref&amp;gt; It is the '''most common cause of primary (idiopathic) nephrotic syndrome in adults''' in the United States and the '''leading glomerular cause of end-stage kidney disease (ESKD)'''.&amp;lt;ref name=&amp;quot;CJASN&amp;quot;&amp;gt;Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. ''Clin J Am Soc Nephrol''. 2017;12(3):502-517.&amp;lt;/ref&amp;gt; FSGS disproportionately affects '''African Americans''' (driven by APOL1 risk alleles). The emergency physician encounters FSGS patients presenting with '''nephrotic syndrome''' (massive edema, proteinuria, hypoalbuminemia) and its '''life-threatening complications''': '''thromboembolism''', '''spontaneous bacterial peritonitis''', '''hypovolemic crisis''', '''acute kidney injury''', and '''severe hypertension'''.&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
*'''Diagnosis is histopathologic''' — requires renal biopsy; cannot be diagnosed by clinical features or labs alone&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
*FSGS accounts for ~35% of nephrotic syndrome in adults (higher in Black patients) and 7-20% in children&lt;br /&gt;
*Incidence is increasing worldwide over the past three decades&amp;lt;ref name=&amp;quot;MSD&amp;quot;&amp;gt;Focal Segmental Glomerulosclerosis. ''MSD Manual Professional Edition''. 2025.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Classification===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! Type !! Mechanism !! Key features&lt;br /&gt;
|-&lt;br /&gt;
| '''Primary (idiopathic)''' || Presumed circulating permeability factor injuring podocytes || Nephrotic-range proteinuria; responds to immunosuppression; '''recurs in up to 40% of kidney transplants'''&lt;br /&gt;
|-&lt;br /&gt;
| '''Secondary''' || Adaptive (hyperfiltration) or toxic podocyte injury || Obesity, HIV (HIVAN), heroin, sickle cell, reflux nephropathy, single kidney, anabolic steroids; usually subnephrotic proteinuria&lt;br /&gt;
|-&lt;br /&gt;
| '''Genetic''' || Mutations in podocyte structural proteins (NPHS1, NPHS2, INF2, TRPC6, others) || Steroid-resistant; does NOT recur after transplant; family history&lt;br /&gt;
|-&lt;br /&gt;
| '''APOL1-associated''' || APOL1 G1/G2 risk alleles (sub-Saharan African ancestry) || Explains disproportionate FSGS burden in Black patients; also linked to HIVAN and hypertensive nephrosclerosis&lt;br /&gt;
|-&lt;br /&gt;
| '''Virus-associated''' || HIV (HIVAN), parvovirus B19, CMV, EBV || HIVAN: collapsing variant; almost exclusively in Black patients; responds to antiretroviral therapy&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Histologic variants (prognostic significance)===&lt;br /&gt;
*'''NOS (not otherwise specified):''' most common; intermediate prognosis&lt;br /&gt;
*'''Tip lesion:''' best prognosis; most responsive to steroids&lt;br /&gt;
*'''Collapsing:''' worst prognosis; associated with HIVAN, severe hypertension, rapid progression to ESKD; massive proteinuria; steroid-resistant&lt;br /&gt;
*'''Cellular:''' intermediate prognosis&lt;br /&gt;
*'''Perihilar:''' associated with adaptive/secondary FSGS&lt;br /&gt;
&lt;br /&gt;
==Clinical features==&lt;br /&gt;
===Nephrotic syndrome (&amp;gt;70% of primary FSGS)===&lt;br /&gt;
*'''Edema:''' generalized or dependent; may develop over weeks or have '''abrupt onset with 15-20 lb weight gain'''&amp;lt;ref name=&amp;quot;Medscape_FSGS&amp;quot;&amp;gt;Focal Segmental Glomerulosclerosis Clinical Presentation. ''Medscape''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Children: typically begins with '''periorbital/facial swelling''' → progresses to generalized anasarca&lt;br /&gt;
**Adults: dependent edema (legs, sacrum); periorbital&lt;br /&gt;
*'''Foamy urine''' (proteinuria)&lt;br /&gt;
*'''Fatigue, anorexia'''&lt;br /&gt;
*'''Ascites, pleural effusions''' (from third-spacing; pericardial effusion is rare)&lt;br /&gt;
*Onset frequently follows an '''upper respiratory tract infection'''&lt;br /&gt;
*'''Hypertension''' — may be '''severe''' (diastolic &amp;gt;120 mmHg), especially in Black patients with renal impairment&amp;lt;ref name=&amp;quot;StatPearls&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Subnephrotic presentation (~30%)===&lt;br /&gt;
*Incidental proteinuria found on routine urinalysis&lt;br /&gt;
*Microscopic hematuria (occasionally)&lt;br /&gt;
*Mild hypertension&lt;br /&gt;
*Slowly progressive renal insufficiency&lt;br /&gt;
&lt;br /&gt;
===EM-relevant complications of nephrotic syndrome===&lt;br /&gt;
These are the reasons FSGS patients present to the ED:&lt;br /&gt;
&lt;br /&gt;
====Thromboembolism====&lt;br /&gt;
*Nephrotic syndrome is a '''hypercoagulable state''' — urinary loss of antithrombin III, protein C, protein S; elevated fibrinogen, factor V, factor VIII; platelet hyperaggregability&amp;lt;ref name=&amp;quot;Complications&amp;quot;&amp;gt;Complications of nephrotic syndrome. ''Korean J Pediatr''. 2011;54(8):322-328. PMC3212701.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Risk: '''deep venous thrombosis, pulmonary embolism, renal vein thrombosis, cerebral sinus thrombosis'''&lt;br /&gt;
*VTE incidence ~1-5% in adults (higher in membranous nephropathy); risk is highest in the '''first 6 months'''&lt;br /&gt;
*'''Sudden gross hematuria or acute flank pain + acute renal failure''' → suspect '''renal vein thrombosis'''&lt;br /&gt;
*'''Acute dyspnea + pleuritic chest pain''' → suspect '''pulmonary embolism'''&lt;br /&gt;
*Children: arterial thrombosis (cerebrovascular) can also occur&lt;br /&gt;
&lt;br /&gt;
====Infection====&lt;br /&gt;
*'''Immunodeficiency''' from urinary loss of immunoglobulins (especially IgG) and complement proteins&lt;br /&gt;
*Immunosuppressive therapy further increases risk&lt;br /&gt;
*'''Most common infections:''' pneumonia, sepsis/bacteremia, cellulitis, '''spontaneous bacterial peritonitis (SBP)''', UTI&amp;lt;ref name=&amp;quot;Complications&amp;quot;/&amp;gt;&lt;br /&gt;
*'''SBP in nephrotic syndrome:''' any child with nephrotic syndrome + fever + abdominal pain + ascites should have '''diagnostic paracentesis''' — ''Streptococcus pneumoniae'' is the most common causative organism; ''E. coli'' and gram-negatives also seen&lt;br /&gt;
*Steroid therapy may '''mask typical signs of infection''' — maintain a high index of suspicion&lt;br /&gt;
&lt;br /&gt;
====Hypovolemic crisis====&lt;br /&gt;
*Severe hypoalbuminemia (albumin &amp;lt;1.5 g/dL) → decreased oncotic pressure → intravascular volume depletion&lt;br /&gt;
*'''Abdominal pain, vomiting, diarrhea, tachycardia, cool extremities, delayed capillary refill, oliguria''' → '''hypotension''' (a late sign)&amp;lt;ref name=&amp;quot;Complications&amp;quot;/&amp;gt;&lt;br /&gt;
*Can be precipitated by aggressive diuresis or intercurrent illness&lt;br /&gt;
*'''Risk of AKI from prerenal azotemia'''&lt;br /&gt;
&lt;br /&gt;
====Acute kidney injury====&lt;br /&gt;
*Multifactorial: hypovolemia, sepsis, nephrotoxic medications, renal vein thrombosis, or disease progression&lt;br /&gt;
*AKI complicating NS has increased 158% over the past decade in pediatric hospitalizations&amp;lt;ref name=&amp;quot;AKI_NS&amp;quot;&amp;gt;Rheault MN, et al. Increasing frequency of AKI amongst children hospitalized with nephrotic syndrome. ''Pediatr Nephrol''. 2014;29(1):139-147. PMC6556228.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====Severe/malignant hypertension====&lt;br /&gt;
*May present with hypertensive emergency: headache, visual changes, encephalopathy, seizures&lt;br /&gt;
&lt;br /&gt;
==Differential diagnosis==&lt;br /&gt;
===Nephrotic syndrome (other causes)===&lt;br /&gt;
*'''Minimal change disease (MCD):''' most common cause in children; clinically indistinguishable from FSGS without biopsy; steroid-responsive; excellent prognosis (distinguishing MCD from FSGS on biopsy is critical because management and prognosis differ)&lt;br /&gt;
*'''Membranous nephropathy:''' most common in white adults; strongly associated with renal vein thrombosis; may be secondary to malignancy, hepatitis B, SLE&lt;br /&gt;
*'''Diabetic nephropathy:''' most common secondary cause of nephrotic syndrome overall&lt;br /&gt;
*'''Lupus nephritis''' ([[SLE]])&lt;br /&gt;
*'''Amyloidosis'''&lt;br /&gt;
*'''IgA nephropathy''' (nephrotic presentation less common)&lt;br /&gt;
*'''HIV-associated nephropathy (HIVAN):''' collapsing FSGS variant; suspect in any HIV-positive patient with nephrotic syndrome&lt;br /&gt;
&lt;br /&gt;
===Generalized edema (non-renal causes to exclude)===&lt;br /&gt;
*'''Heart failure''' (elevated JVP, S3 gallop, pulmonary edema)&lt;br /&gt;
*'''Cirrhosis/hepatic failure''' (spider angiomata, ascites, jaundice, coagulopathy)&lt;br /&gt;
*'''Protein-losing enteropathy'''&lt;br /&gt;
*'''Severe malnutrition'''&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===ED workup===&lt;br /&gt;
*'''Urinalysis with microscopy:'''&lt;br /&gt;
**'''Heavy proteinuria''' (3+ or 4+ on dipstick)&lt;br /&gt;
**Hyaline or broad waxy casts; '''RBC casts are generally absent''' (their presence suggests nephritic syndrome/glomerulonephritis instead)&lt;br /&gt;
**Oval fat bodies (&amp;quot;Maltese cross&amp;quot; under polarized light) — pathognomonic for nephrotic-range proteinuria&lt;br /&gt;
*'''Spot urine protein:creatinine ratio:''' &amp;gt;3.5 mg/mg indicates nephrotic-range proteinuria (faster than 24-hour collection)&lt;br /&gt;
*'''Serum albumin:''' &amp;lt;3.0 g/dL (often &amp;lt;2.0 g/dL in active disease)&lt;br /&gt;
*'''BMP/CMP:''' creatinine (renal function), electrolytes, calcium (low from hypoalbuminemia — correct for albumin)&lt;br /&gt;
*'''Lipid panel:''' hyperlipidemia (elevated total cholesterol, LDL, triglycerides) — characteristic of nephrotic syndrome&lt;br /&gt;
*'''CBC:''' evaluate for infection; anemia (may occur from transferrin loss)&lt;br /&gt;
*'''Coagulation studies:''' PT/INR, fibrinogen (if thrombosis suspected)&lt;br /&gt;
*'''Blood glucose:''' rule out diabetic nephropathy as underlying cause&lt;br /&gt;
&lt;br /&gt;
===Directed testing based on presentation===&lt;br /&gt;
*'''Suspected thromboembolism:''' D-dimer, CT pulmonary angiography (PE), Doppler ultrasound of extremities (DVT), renal vein Doppler (renal vein thrombosis)&lt;br /&gt;
*'''Suspected SBP:''' diagnostic paracentesis (cell count, Gram stain, culture, protein, albumin)&lt;br /&gt;
*'''Suspected infection:''' blood cultures, urine culture, chest X-ray&lt;br /&gt;
*'''New diagnosis workup''' (arrange via nephrology; not all ED tests):&lt;br /&gt;
**Complement levels (C3, C4) — normal in FSGS (low in SLE, MPGN, post-infectious GN)&lt;br /&gt;
**ANA, anti-dsDNA (lupus)&lt;br /&gt;
**Hepatitis B and C serologies&lt;br /&gt;
**HIV testing&lt;br /&gt;
**Serum free light chains, SPEP/UPEP (amyloidosis, myeloma)&lt;br /&gt;
**'''Renal biopsy:''' definitive diagnosis; arranged by nephrology&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
===ED management of nephrotic syndrome complications===&lt;br /&gt;
&lt;br /&gt;
====Edema management====&lt;br /&gt;
*'''Salt restriction''' (education; not acute ED intervention)&lt;br /&gt;
*'''Loop diuretics:''' furosemide 1-2 mg/kg IV (children) or 20-80 mg IV (adults)&lt;br /&gt;
**'''Caution:''' excessive diuresis can precipitate hypovolemic crisis and AKI — monitor volume status carefully&lt;br /&gt;
**Diuretic resistance is common in severe hypoalbuminemia (furosemide is protein-bound and may not reach tubular lumen effectively)&lt;br /&gt;
*'''IV albumin 25% (0.5-1 g/kg) followed immediately by IV furosemide:''' for '''severe/refractory edema''' or clinical hypovolemia&lt;br /&gt;
**Albumin temporarily raises oncotic pressure, mobilizes edema fluid into intravascular space, and enhances diuretic delivery to the kidney&lt;br /&gt;
**'''Monitor closely for pulmonary edema''' — albumin infusion can cause fluid overload if the patient is not truly volume-depleted&lt;br /&gt;
*'''Do NOT give albumin without concurrent diuresis''' unless treating confirmed hypovolemia — it will redistribute into the extravascular space and worsen edema&lt;br /&gt;
&lt;br /&gt;
====Thromboembolism====&lt;br /&gt;
*'''Anticoagulation:''' heparin (UFH or LMWH) followed by warfarin or DOAC per VTE protocols&lt;br /&gt;
*'''Thrombolysis or thrombectomy:''' consider for massive PE or limb-threatening DVT per standard protocols&lt;br /&gt;
*Renal vein thrombosis: anticoagulation; rarely requires intervention&lt;br /&gt;
&lt;br /&gt;
====Infection / SBP====&lt;br /&gt;
*'''Empiric antibiotics:''' broad-spectrum pending cultures&lt;br /&gt;
*'''SBP:''' cefotaxime or ceftriaxone (covers ''S. pneumoniae'' and gram-negatives); adjust based on culture&lt;br /&gt;
*'''Diagnostic paracentesis''' in any nephrotic patient with ascites + fever or abdominal pain — do not wait for imaging&lt;br /&gt;
&lt;br /&gt;
====Hypovolemic crisis====&lt;br /&gt;
*'''IV normal saline 20 mL/kg bolus''' if hemodynamically compromised&lt;br /&gt;
*'''IV albumin 25% (1 g/kg over 3-5 hours)''' for severe hypovolemia with albumin &amp;lt;1.5 g/dL&lt;br /&gt;
*Monitor blood pressure closely; avoid fluid overload&lt;br /&gt;
&lt;br /&gt;
====Hypertensive emergency====&lt;br /&gt;
*Manage per standard [[Hypertensive emergency]] protocols&lt;br /&gt;
*ACE inhibitors/ARBs are first-line for chronic BP control AND reduce proteinuria (but avoid in AKI with hyperkalemia)&lt;br /&gt;
&lt;br /&gt;
===Disease-specific treatment (not typically initiated in ED)===&lt;br /&gt;
*'''Primary FSGS:''' corticosteroids (prednisone 1 mg/kg/day for 16+ weeks in adults); calcineurin inhibitors (tacrolimus, cyclosporine) for steroid-resistant or intolerant; mycophenolate mofetil; rituximab&lt;br /&gt;
*'''Secondary FSGS:''' treat underlying cause (antiretroviral therapy for HIV, weight loss for obesity, stop offending drug); ACE inhibitor/ARB for proteinuria reduction&lt;br /&gt;
*'''Genetic FSGS:''' does NOT respond to immunosuppression; ACE inhibitor/ARB and supportive care&lt;br /&gt;
*All patients: '''ACE inhibitor or ARB''' (reduces proteinuria independent of blood pressure), '''statins''' (for hyperlipidemia), '''sodium restriction'''&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''Admit:'''&lt;br /&gt;
**Severe/symptomatic edema unresponsive to oral diuretics&lt;br /&gt;
**Thromboembolism (PE, DVT, renal vein thrombosis, cerebral sinus thrombosis)&lt;br /&gt;
**Suspected or confirmed SBP or sepsis&lt;br /&gt;
**Hypovolemic crisis with hemodynamic instability&lt;br /&gt;
**AKI (rising creatinine, oliguria)&lt;br /&gt;
**Hypertensive emergency&lt;br /&gt;
**New diagnosis with severe nephrotic syndrome requiring urgent nephrology evaluation&lt;br /&gt;
*'''Discharge with close follow-up:'''&lt;br /&gt;
**Known FSGS patient with stable mild-moderate edema exacerbation responsive to oral diuretics&lt;br /&gt;
**No signs of infection, thrombosis, or AKI&lt;br /&gt;
**Stable renal function&lt;br /&gt;
**Ensure nephrology follow-up within 24-72 hours&lt;br /&gt;
*'''Always refer to nephrology''' — FSGS requires biopsy for diagnosis and ongoing specialist management; the EM physician's role is to manage complications and ensure timely referral&lt;br /&gt;
*'''Counsel patients on:'''&lt;br /&gt;
**Sodium restriction&lt;br /&gt;
**'''Signs of thromboembolism''' (leg swelling, dyspnea, chest pain) — seek immediate care&lt;br /&gt;
**'''Signs of infection''' (fever, abdominal pain) — low threshold to return&lt;br /&gt;
**Medication compliance (steroids, immunosuppressants, ACE inhibitors)&lt;br /&gt;
**'''Pneumococcal vaccination''' (if not already received — nephrotic patients are at high risk for pneumococcal infection)&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Nephrotic syndrome]]&lt;br /&gt;
*[[Nephritic syndrome]]&lt;br /&gt;
*[[Acute kidney injury]]&lt;br /&gt;
*[[Pulmonary embolism]]&lt;br /&gt;
*[[Deep venous thrombosis]]&lt;br /&gt;
*[[Spontaneous bacterial peritonitis]]&lt;br /&gt;
*[[Hypertensive emergency]]&lt;br /&gt;
*[[HIV]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK532272/ StatPearls — Focal Segmental Glomerulosclerosis]&lt;br /&gt;
*[https://journals.lww.com/cjasn/fulltext/2017/03000/focal_segmental_glomerulosclerosis.18.aspx CJASN — Focal Segmental Glomerulosclerosis (Rosenberg &amp;amp; Kopp, 2017)]&lt;br /&gt;
*[https://emedicine.medscape.com/article/245915-overview Medscape — Focal Segmental Glomerulosclerosis]&lt;br /&gt;
*[https://www.msdmanuals.com/professional/genitourinary-disorders/glomerular-disorders/focal-segmental-glomerulosclerosis MSD Manual — Focal Segmental Glomerulosclerosis]&lt;br /&gt;
*[https://www.kidney.org/kidney-topics/focal-segmental-glomerulosclerosis-fsgs NKF — Focal Segmental Glomerulosclerosis]&lt;br /&gt;
*[https://pmc.ncbi.nlm.nih.gov/articles/PMC3212701/ Korean J Pediatr — Complications of nephrotic syndrome (2011)]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Renal]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>